{"gene":"WFS1","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":1998,"finding":"WFS1 encodes a predicted transmembrane protein (wolframin) expressed in various tissues including brain and pancreas; loss-of-function mutations in both alleles cause Wolfram syndrome, establishing it as the disease gene on chromosome 4p16.","method":"Positional cloning, candidate gene screening, mutation analysis in Wolfram syndrome patients","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — positional cloning with direct mutation identification in patients, replicated across multiple subsequent studies","pmids":["9817917"],"is_preprint":false},{"year":2001,"finding":"WFS1 protein (wolframin) is an integral, endoglycosidase H-sensitive membrane glycoprotein that localizes primarily to the endoplasmic reticulum (ER); no co-localization with mitochondria was detected, arguing against a mitochondrial-mediated disorder mechanism.","method":"Immunofluorescence, subcellular fractionation, endoglycosidase H sensitivity assay, co-localization with ER marker in cultured cells","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal biochemical and imaging methods in one study; ER localization replicated by multiple subsequent labs","pmids":["11181571"],"is_preprint":false},{"year":2003,"finding":"Wolframin contains nine transmembrane segments with N-cytoplasmic/C-luminal (N(cyt)/C(lum)) topology, assembles into higher molecular weight complexes (~400 kDa) in the membrane, and undergoes N-glycosylation (essential for biogenesis and stability) but lacks proteolytic processing. Missense mutation R629W causes instability and strongly reduced half-life of wolframin.","method":"Polyclonal antibody generation against both termini, topology mapping, pulse-chase experiments, COS-7 cell expression of mutant wolframin","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biochemical reconstitution with mutagenesis and pulse-chase in single rigorous study with multiple orthogonal methods","pmids":["12913071"],"is_preprint":false},{"year":2004,"finding":"ER stress upregulates WFS1 mRNA and protein in pancreatic islets; N-glycosylation at Asn-663 and Asn-748 is required for WFS1 protein stability — glycosylation-defective mutants show increased protein turnover.","method":"ER stress induction with thapsigargin/dithiothreitol/tunicamycin, site-directed mutagenesis, pulse-chase protein stability assays","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — site-directed mutagenesis combined with pulse-chase stability assays in one study","pmids":["15522226"],"is_preprint":false},{"year":2004,"finding":"Wfs1-null mice develop progressive beta-cell loss and impaired insulin secretion in response to glucose, accompanied by reduced cellular calcium responses to secretagogues and increased apoptosis of beta-cells under ER stress conditions; alpha-cells which barely express WFS1 are preserved.","method":"Wfs1 gene disruption in mice, glucose tolerance tests, islet isolation and insulin secretion assays, calcium imaging, immunohistochemistry, DNA fragmentation apoptosis assay","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO mouse model with multiple orthogonal functional readouts","pmids":["15056606"],"is_preprint":false},{"year":2005,"finding":"WFS1 is a novel component of the unfolded protein response (UPR); WFS1 mRNA and protein are induced by ER stress through IRE1 and PERK pathways; WFS1 is upregulated during insulin secretion; inactivation of WFS1 in beta-cells causes ER stress and beta-cell dysfunction.","method":"ER stress induction, siRNA knockdown of WFS1 in beta-cells, UPR pathway reporter assays, IRE1/PERK pathway analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods; replicated by multiple subsequent studies","pmids":["16195229"],"is_preprint":false},{"year":2006,"finding":"WFS1-deficiency specifically activates the ER stress response in pancreatic beta-cells (elevated PERK phosphorylation, chaperone expression, active XBP1) but not in heart, skeletal muscle, or brown adipose tissue; this is reversed by re-expression of WFS1 or GRP78 overexpression. ER stress-induced increase in p21(CIP1) contributes to beta-cell loss through impaired cell cycle progression and increased caspase-3-mediated apoptosis.","method":"wfs1-deficient MIN6 clonal beta-cell lines, ER stress markers (PERK phosphorylation, XBP1, chaperone expression), BrdU incorporation, caspase-3 cleavage, WFS1 rescue experiments, GRP78 overexpression rescue","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — rescue experiments with multiple orthogonal readouts in both primary islets and clonal cell lines","pmids":["16571599"],"is_preprint":false},{"year":2006,"finding":"WFS1 protein positively modulates ER Ca2+ levels by increasing the rate of Ca2+ uptake into the ER; store-operated Ca2+ entry parallels WFS1 expression levels.","method":"WFS1 knockdown and overexpression in HEK293 cells, ER-targeted Ca2+-sensitive aequorin photoprotein, Fura-2 Ca2+ imaging","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct Ca2+ measurement with ER-targeted aequorin combined with both gain- and loss-of-function in one study","pmids":["16989814"],"is_preprint":false},{"year":2009,"finding":"Valproate (a mood stabilizer) induces WFS1 mRNA expression, activates the WFS1 promoter, and dose-dependently enhances dissociation of WFS1 from its binding partner GRP94 (an ER stress-response protein), providing a molecular mechanism for valproate's action.","method":"WFS1 promoter luciferase assay, RT-PCR, co-immunoprecipitation of WFS1-GRP94 complex in cells treated with valproate","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP combined with reporter assay and mRNA analysis, single lab, two orthogonal methods","pmids":["19125190"],"is_preprint":false},{"year":2011,"finding":"WFS1 localizes not only to the ER but also to secretory granules in pancreatic beta-cells; WFS1-deficiency causes a 32% reduction in granular acidification, impairs proinsulin processing, and reduces the density of secretory granules docked at the plasma membrane.","method":"Immunofluorescence, electron microscopy, acidotrophic agent (DAMP) fluorescence measurement of intragranular pH, morphometric electron microscopy analysis of docked granules, proinsulin/insulin measurement","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (immunofluorescence, EM, functional acidification assay) in single rigorous study","pmids":["21199859"],"is_preprint":false},{"year":2012,"finding":"WFS1 physically interacts with the V1A subunit of the vacuolar H+-ATPase (proton pump) via its N-terminal domain; WFS1 is required for V1A subunit stability (V1A is degraded more rapidly in WFS1-depleted cells), suggesting WFS1 functions in proton pump assembly in the ER and granular acidification.","method":"Co-immunoprecipitation in HEK293 cells and endogenous Co-IP in neuroblastoma cells, V1A domain mapping (N-terminal vs C-terminal of WFS1), protein stability assays, proteasomal inhibition, WFS1 stable/transient depletion in human neuroblastoma and NT2 cells","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with endogenous proteins, domain mapping, and protein stability assays in multiple cell lines","pmids":["23035048"],"is_preprint":false},{"year":2014,"finding":"ATF6β (but not ATF6α) directly binds the WFS1 promoter and induces WFS1 gene and protein expression; ATF6β knockdown increases susceptibility to ER stress-induced apoptosis in beta-cells, partly through its failure to upregulate WFS1.","method":"Microarray after ATF6β/ATF6α overexpression, promoter binding assay (ChIP/binding assay), ATF6β knockdown in INS-1 cells, apoptosis assay","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter binding combined with KD rescue and apoptosis readout, single lab","pmids":["25447309"],"is_preprint":false},{"year":2021,"finding":"WFS1 acts as a vesicular cargo receptor for ER-to-Golgi transport: it directly binds vesicular cargo proteins including proinsulin via its ER-luminal C-terminal segment, and its cytosolic N-terminal segment encodes an ER export signal recognized by COPII subunit SEC24. WFS1 deficiency causes abnormal ER accumulation of proinsulin, impairing proinsulin processing and insulin secretion. Pathogenic mutations in the C-terminal luminal region disrupt cargo binding.","method":"Co-IP/pulldown of WFS1 with proinsulin and other cargo proteins, COPII vesicle reconstitution, SEC24 binding assays, domain mutagenesis, WFS1 KO cells, proinsulin trafficking and processing assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution of COPII vesicle formation, direct binding assays with mutagenesis, and loss-of-function cellular readout in one rigorous study","pmids":["34848728"],"is_preprint":false},{"year":2021,"finding":"WFS1 deficiency in peripheral blood mononuclear cells (PBMCs) and silencing via siRNA induces production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) without any exogenous stimulus, and promotes a Th17/Treg imbalance, indicating WFS1 regulates anti-inflammatory responses.","method":"WFS1 siRNA silencing in control PBMCs, cytokine measurement by ELISA, T-cell subset analysis (Th17/Treg) by flow cytometry in WS patient PBMCs","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with cytokine and flow cytometry readouts; single lab","pmids":["33693650"],"is_preprint":false},{"year":2022,"finding":"Loss of WFS1 function enhances pro-inflammatory cytokine and chemokine expression in pancreatic beta-cells; PERK and IRE1α pathways mediate high glucose-induced inflammation; WFS1 whole-body KO mice show M1-macrophage infiltration and hypervascularization of pancreatic islets.","method":"WFS1-deficient beta-cell model, qPCR for pro-inflammatory gene expression, Wfs1 KO mouse pancreatic islet histology, macrophage immunostaining","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro WFS1 KO cell model combined with in vivo mouse histology, single lab","pmids":["35399956"],"is_preprint":false},{"year":2023,"finding":"WFS1 (Wfs1E864K knock-in) is required for endocochlear potential (EP) production in the stria vascularis; the WFS1E864K mutation prevents localization of the Na+/K+-ATPase β1 subunit to the cell surface, collapsing the EP and causing profound deafness.","method":"Wfs1E864K knock-in mouse model, EP measurement, stria vascularis histology, Na+/K+-ATPase β1 subunit localization by immunofluorescence, auditory brainstem response (ABR)","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 / Moderate — knock-in model with direct EP measurement and mechanistic protein localization assay; single lab but multiple orthogonal readouts","pmids":["37386014"],"is_preprint":false},{"year":2023,"finding":"WFS1 interacts with VDAC1 at mitochondria-associated ER membranes (MAMs); loss of WFS1-VDAC1 interaction in Wolfram syndrome patient-derived hiPSC neurons correlates with mitochondrial dysfunction, reduced MAMs, and impaired bioenergetics; restoring WFS1 levels reinstates VDAC1 interaction, increases MAMs, and improves mitochondrial function.","method":"Co-IP of WFS1 with VDAC1 in hiPSC-derived neurons, mitochondrial function assays (OCR), MAM quantification by electron microscopy, WFS1 overexpression rescue, pharmacological agents modulating mitochondrial function","journal":"Stem cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP in human iPSC-derived neurons with rescue experiments and multiple functional readouts in a single rigorous study","pmids":["37163979"],"is_preprint":false},{"year":2024,"finding":"WFS1E864K (Wolfram-like syndrome mutation) decreases MAM number, reduces ER-to-mitochondria Ca2+ transfer, impairs mitochondrial bioenergetics and Ca2+ uptake, and deregulates autophagy/mitophagy flux in human fibroblasts and murine neuronal cultures; these are similar pathophysiological mechanisms to those in Wolfram syndrome.","method":"Human WLS fibroblasts and murine neuronal cultures, mitochondrial bioenergetics (OCR), Ca2+ uptake assays, MAM quantification by electron microscopy, autophagic flux assays (bafilomycin A1), mitophagy assays","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal functional assays in patient-derived cells; single lab","pmids":["38651637"],"is_preprint":false},{"year":2024,"finding":"WFS1-expressing glutamatergic neurons in the basolateral amygdala (BLA) have their excitability modulated by adjacent astrocytes via D-serine acting on NMDA receptors; optogenetic activation of BLA astrocytes restores BLAWFS1 neuron firing and risk-assessment behavior in a DISC1-N mouse model.","method":"Single-nucleus RNA sequencing to identify BLAWFS1 neurons, patch-clamp electrophysiology, optogenetic astrocyte activation, NMDA receptor pharmacology, real-time RT-PCR","journal":"Neuron","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — optogenetics combined with electrophysiology and pharmacology; defines circuit role of WFS1 neurons but single lab","pmids":["38642554"],"is_preprint":false},{"year":2020,"finding":"Dominant WFS1 mutants (p.His313Tyr, p.Trp314Arg, p.Asp325_Ile328del, p.Glu809Lys, p.Glu864Lys) exert a dominant-negative effect on wild-type WFS1, increasing ER stress (ERSE-luciferase) and CHOP mRNA; treatment with 4-phenylbutyrate or valproate reduces ER stress and cell apoptosis caused by these mutants.","method":"ERSE-luciferase ER stress reporter assay with dominant mutant co-expression, CHOP mRNA qPCR, cell viability assays, PBA/VPA pharmacological treatment","journal":"Journal of endocrinological investigation","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — luciferase reporter assay with multiple mutants; dominant-negative mechanism established by co-expression approach in single lab","pmids":["32219690"],"is_preprint":false}],"current_model":"WFS1 (wolframin) is a multi-spanning ER transmembrane glycoprotein that (1) acts as a vesicular cargo receptor by binding proinsulin and other secretory proteins via its luminal C-terminus and presenting an ER export signal on its cytosolic N-terminus to SEC24/COPII for ER-to-Golgi trafficking; (2) is a key component of the unfolded protein response whose expression is induced by ER stress through IRE1/PERK/ATF6β pathways; (3) modulates ER Ca2+ levels by promoting Ca2+ uptake and filling of the ER store; (4) interacts with the V1A subunit of vacuolar H+-ATPase to stabilize the proton pump and support secretory granule acidification and proinsulin processing; (5) localizes to mitochondria-associated ER membranes (MAMs) where it binds VDAC1 to support mitochondrial Ca2+ transfer and bioenergetics; (6) interacts with GRP94 in the ER and with Na+/K+-ATPase β1 subunit in the stria vascularis cochlea to maintain the endocochlear potential; and (7) suppresses ER stress-mediated inflammation, apoptosis, and beta-cell loss, with its deficiency causing chronic ER stress, impaired insulin secretion, and progressive neurodegeneration underlying Wolfram syndrome."},"narrative":{"mechanistic_narrative":"WFS1 (wolframin) is a multi-spanning, N-glycosylated endoplasmic reticulum transmembrane protein that maintains ER homeostasis and secretory function, and whose biallelic loss-of-function mutations cause Wolfram syndrome [PMID:9817917, PMID:11181571, PMID:12913071]. It is an integral ER glycoprotein with nine transmembrane segments and N-cytoplasmic/C-luminal topology that assembles into ~400 kDa complexes, and its N-glycosylation is essential for protein stability [PMID:11181571, PMID:12913071, PMID:15522226]. WFS1 functions as a vesicular cargo receptor for ER-to-Golgi transport, binding proinsulin and other secretory cargo through its luminal C-terminal segment while presenting a cytosolic N-terminal ER export signal recognized by the COPII subunit SEC24; its deficiency causes ER accumulation of proinsulin and impaired insulin secretion [PMID:34848728]. Beyond trafficking, WFS1 is an integral component of the unfolded protein response, with its expression induced by ER stress through the IRE1, PERK, and ATF6β arms, and it restrains ER stress-driven apoptosis in pancreatic beta-cells [PMID:16195229, PMID:16571599, PMID:25447309]. It supports secretory granule acidification and proinsulin processing by binding and stabilizing the V1A subunit of the vacuolar H+-ATPase [PMID:21199859, PMID:23035048], and it positively modulates ER Ca2+ uptake [PMID:16989814]. At mitochondria-associated ER membranes WFS1 binds VDAC1 to sustain ER-to-mitochondria Ca2+ transfer and bioenergetics [PMID:37163979, PMID:38651637], and in the cochlear stria vascularis it is required for surface localization of the Na+/K+-ATPase β1 subunit and the endocochlear potential [PMID:37386014]. WFS1 deficiency triggers chronic ER stress, progressive beta-cell loss, and pro-inflammatory responses, mechanistically linking the protein to the diabetes, deafness, and neurodegeneration of Wolfram syndrome [PMID:15056606, PMID:33693650, PMID:35399956].","teleology":[{"year":1998,"claim":"Established that WFS1 is the causative gene for Wolfram syndrome, framing all subsequent mechanistic work as defining how a transmembrane protein causes a multisystem disorder.","evidence":"Positional cloning and mutation analysis in Wolfram syndrome patients","pmids":["9817917"],"confidence":"High","gaps":["Did not define subcellular localization or molecular function","No biochemical activity assigned"]},{"year":2001,"claim":"Answered where wolframin acts by showing it is an ER-resident integral membrane glycoprotein, redirecting the field away from a mitochondrial-primary mechanism.","evidence":"Immunofluorescence, subcellular fractionation, and endoglycosidase H sensitivity in cultured cells","pmids":["11181571"],"confidence":"High","gaps":["No molecular function or topology defined","Did not address later-described MAM/mitochondrial coupling"]},{"year":2003,"claim":"Defined the protein architecture, showing nine transmembrane segments, N-cyt/C-lum topology, oligomerization into ~400 kDa complexes, and that glycosylation and the R629W mutation control stability.","evidence":"Topology mapping, pulse-chase, and mutant expression in COS-7 cells","pmids":["12913071"],"confidence":"High","gaps":["Function of the luminal/cytosolic termini not assigned","Composition of the higher-order complex unknown"]},{"year":2004,"claim":"Linked WFS1 to the ER stress response and beta-cell survival, showing ER stress induces WFS1 and that its loss causes progressive beta-cell apoptosis and impaired glucose-stimulated insulin secretion.","evidence":"Wfs1-null mice with glucose tolerance, insulin secretion, calcium imaging, and apoptosis assays; ER-stress-induced WFS1 with glycosylation-dependent stability in islets","pmids":["15056606","15522226"],"confidence":"High","gaps":["Molecular target by which WFS1 limits apoptosis not identified","Mechanism of reduced calcium responses unresolved"]},{"year":2006,"claim":"Positioned WFS1 as a UPR component induced via IRE1/PERK whose loss causes beta-cell-specific chronic ER stress, with rescue by WFS1 or GRP78 re-expression and p21-driven cell-cycle/apoptosis defects.","evidence":"siRNA knockdown and WFS1/GRP78 rescue in beta-cell lines and islets with UPR markers, BrdU, and caspase-3 readouts","pmids":["16195229","16571599"],"confidence":"High","gaps":["Direct biochemical role of WFS1 within the UPR not defined","Tissue specificity mechanism unexplained"]},{"year":2006,"claim":"Assigned a calcium-handling function, showing WFS1 levels positively set the rate of ER Ca2+ uptake and store-operated entry.","evidence":"Knockdown/overexpression in HEK293 cells with ER-targeted aequorin and Fura-2 imaging","pmids":["16989814"],"confidence":"High","gaps":["Molecular mechanism of Ca2+ regulation (channel/pump partner) not identified","Relationship to UPR induction unclear"]},{"year":2011,"claim":"Extended WFS1 function to secretory granules, showing it is required for granular acidification, proinsulin processing, and granule docking.","evidence":"Immunofluorescence, EM, DAMP intragranular pH measurement, and morphometry in beta-cells","pmids":["21199859"],"confidence":"High","gaps":["Molecular basis of acidification defect not yet defined","Did not identify the proton-pump partner"]},{"year":2012,"claim":"Provided a mechanism for acidification by showing WFS1 binds and stabilizes the vacuolar H+-ATPase V1A subunit via its N-terminal domain.","evidence":"Reciprocal endogenous Co-IP, domain mapping, and protein stability assays in HEK293 and neuroblastoma cells","pmids":["23035048"],"confidence":"High","gaps":["Stoichiometry within the ~400 kDa complex unresolved","Direct vs indirect stabilization not distinguished"]},{"year":2014,"claim":"Identified ATF6β as a direct transcriptional inducer of WFS1, separating ATF6β from ATF6α in protecting beta-cells from ER-stress apoptosis.","evidence":"Microarray, promoter binding, and ATF6β knockdown with apoptosis assays in INS-1 cells","pmids":["25447309"],"confidence":"Medium","gaps":["Single lab; reciprocal validation limited","Quantitative contribution of WFS1 to ATF6β protection not isolated"]},{"year":2021,"claim":"Defined WFS1's core molecular activity as a COPII cargo receptor, showing direct luminal binding of proinsulin and other cargo and an N-terminal ER export signal recognized by SEC24, with pathogenic luminal mutations disrupting cargo binding.","evidence":"Co-IP/pulldown, COPII vesicle reconstitution, SEC24 binding, domain mutagenesis, and trafficking assays in WFS1 KO cells","pmids":["34848728"],"confidence":"High","gaps":["Full repertoire of cargo proteins not catalogued","Reconciliation with UPR and Ca2+ roles within one mechanism not established"]},{"year":2021,"claim":"Implicated WFS1 in immune regulation, showing its loss drives spontaneous pro-inflammatory cytokine production and Th17/Treg imbalance in immune cells.","evidence":"siRNA silencing in PBMCs with ELISA cytokine measurement and flow cytometry of T-cell subsets","pmids":["33693650"],"confidence":"Medium","gaps":["Mechanism linking WFS1 loss to cytokine induction not defined","Single lab; no in vivo confirmation in this study"]},{"year":2023,"claim":"Established a MAM/mitochondrial role, showing WFS1 binds VDAC1 to maintain ER-mitochondria contacts and bioenergetics, with rescue restoring function.","evidence":"Co-IP, OCR, EM MAM quantification, and WFS1 overexpression rescue in Wolfram patient hiPSC-derived neurons","pmids":["37163979"],"confidence":"High","gaps":["Direct vs indirect WFS1-VDAC1 interaction not resolved","Reconciliation with earlier non-mitochondrial localization not addressed"]},{"year":2023,"claim":"Explained Wolfram-associated deafness, showing WFS1 is required for Na+/K+-ATPase β1 surface localization in the stria vascularis and for the endocochlear potential.","evidence":"Wfs1E864K knock-in mice with EP measurement, ABR, and β1-subunit localization","pmids":["37386014"],"confidence":"High","gaps":["Whether WFS1 directly traffics β1 via its cargo-receptor activity not tested","Single lab"]},{"year":2024,"claim":"Demonstrated that the dominant E864K (Wolfram-like) mutation reduces MAMs, ER-to-mitochondria Ca2+ transfer, bioenergetics, and autophagy/mitophagy flux, unifying dominant and recessive disease mechanisms.","evidence":"OCR, Ca2+ uptake, EM MAM quantification, and autophagy/mitophagy flux assays in patient fibroblasts and murine neurons","pmids":["38651637"],"confidence":"Medium","gaps":["Causal order between Ca2+ defect and autophagy deregulation unclear","Single lab"]},{"year":2024,"claim":"Characterized WFS1-expressing neurons at the circuit level, defining basolateral amygdala WFS1 glutamatergic neurons whose excitability is gated by astrocyte-derived D-serine acting on NMDA receptors.","evidence":"Single-nucleus RNA-seq, patch-clamp, optogenetic astrocyte activation, and NMDA pharmacology in a DISC1-N mouse model","pmids":["38642554"],"confidence":"Medium","gaps":["Cell-autonomous function of WFS1 in these neurons not tested","Relationship to Wolfram neurodegeneration not established"]},{"year":null,"claim":"How WFS1's distinct activities — COPII cargo receptor, UPR effector, ER Ca2+ regulator, V-ATPase stabilizer, MAM/VDAC1 tether, and Na+/K+-ATPase chaperone — derive from a single molecular mechanism, and which is primary in driving each tissue's pathology, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying biochemical model integrating cargo-receptor and ER-homeostasis functions","Tissue-specific primary defect (beta-cell vs cochlea vs neuron) not isolated","Structure of the native oligomeric complex unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0038024","term_label":"cargo receptor activity","supporting_discovery_ids":[12]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[10,15]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[12,16]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,2,3]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[9]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[16,17]}],"pathway":[{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[5,6,11]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[12]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[9,12]}],"complexes":["vacuolar H+-ATPase (V1A subunit)","COPII (via SEC24)","WFS1 ~400 kDa membrane complex"],"partners":["SEC24","ATP6V1A","VDAC1","GRP94","ATP1B1","HSPA5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O76024","full_name":"Wolframin","aliases":[],"length_aa":890,"mass_kda":100.3,"function":"Participates in the regulation of cellular Ca(2+) homeostasis, at least partly, by modulating the filling state of the endoplasmic reticulum Ca(2+) store (PubMed:16989814). Negatively regulates the ER stress response and positively regulates the stability of V-ATPase subunits ATP6V1A and ATP1B1 by preventing their degradation through an unknown proteasome-independent mechanism (PubMed:23035048)","subcellular_location":"Endoplasmic reticulum membrane; Cytoplasmic vesicle, secretory vesicle","url":"https://www.uniprot.org/uniprotkb/O76024/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/WFS1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CALM3","stoichiometry":0.2},{"gene":"CANX","stoichiometry":0.2},{"gene":"CCDC47","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/WFS1","total_profiled":1310},"omim":[{"mim_id":"615649","title":"DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54","url":"https://www.omim.org/entry/615649"},{"mim_id":"614296","title":"WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL","url":"https://www.omim.org/entry/614296"},{"mim_id":"611507","title":"CDGSH IRON SULFUR DOMAIN PROTEIN 2; CISD2","url":"https://www.omim.org/entry/611507"},{"mim_id":"606201","title":"WOLFRAMIN ER TRANSMEMBRANE GLYCOPROTEIN; WFS1","url":"https://www.omim.org/entry/606201"},{"mim_id":"604928","title":"WOLFRAM SYNDROME 2; WFS2","url":"https://www.omim.org/entry/604928"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/WFS1"},"hgnc":{"alias_symbol":["DIDMOAD","WFS"],"prev_symbol":["DFNA6","DFNA14","DFNA38"]},"alphafold":{"accession":"O76024","domains":[{"cath_id":"-","chopping":"339-364_383-567_879-884","consensus_level":"medium","plddt":83.176,"start":339,"end":884},{"cath_id":"2.40.50.140","chopping":"657-715_772-785_797-858","consensus_level":"high","plddt":83.1633,"start":657,"end":858},{"cath_id":"1.25.40","chopping":"88-170","consensus_level":"medium","plddt":89.4751,"start":88,"end":170},{"cath_id":"1.20.5","chopping":"285-335","consensus_level":"high","plddt":67.0396,"start":285,"end":335}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O76024","model_url":"https://alphafold.ebi.ac.uk/files/AF-O76024-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O76024-F1-predicted_aligned_error_v6.png","plddt_mean":73.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=WFS1","jax_strain_url":"https://www.jax.org/strain/search?query=WFS1"},"sequence":{"accession":"O76024","fasta_url":"https://rest.uniprot.org/uniprotkb/O76024.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O76024/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O76024"}},"corpus_meta":[{"pmid":"7490992","id":"PMC_7490992","title":"Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome.","date":"1995","source":"Lancet (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7490992","citation_count":482,"is_preprint":false},{"pmid":"9817917","id":"PMC_9817917","title":"Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9817917","citation_count":379,"is_preprint":false},{"pmid":"16195229","id":"PMC_16195229","title":"WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic beta-cells.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16195229","citation_count":300,"is_preprint":false},{"pmid":"11181571","id":"PMC_11181571","title":"WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11181571","citation_count":271,"is_preprint":false},{"pmid":"15056606","id":"PMC_15056606","title":"Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion.","date":"2004","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15056606","citation_count":217,"is_preprint":false},{"pmid":"16571599","id":"PMC_16571599","title":"WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic beta-cells.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16571599","citation_count":207,"is_preprint":false},{"pmid":"9350817","id":"PMC_9350817","title":"Wolfram (DIDMOAD) syndrome.","date":"1997","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9350817","citation_count":202,"is_preprint":false},{"pmid":"11709537","id":"PMC_11709537","title":"Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11709537","citation_count":188,"is_preprint":false},{"pmid":"12913071","id":"PMC_12913071","title":"Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product.","date":"2003","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12913071","citation_count":164,"is_preprint":false},{"pmid":"16989814","id":"PMC_16989814","title":"WFS1 protein modulates the free Ca(2+) concentration in the endoplasmic reticulum.","date":"2006","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/16989814","citation_count":145,"is_preprint":false},{"pmid":"12955714","id":"PMC_12955714","title":"Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease.","date":"2003","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/12955714","citation_count":142,"is_preprint":false},{"pmid":"11317350","id":"PMC_11317350","title":"WFS1/wolframin mutations, Wolfram syndrome, and associated diseases.","date":"2001","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/11317350","citation_count":125,"is_preprint":false},{"pmid":"11709538","id":"PMC_11709538","title":"Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11709538","citation_count":114,"is_preprint":false},{"pmid":"20738327","id":"PMC_20738327","title":"Wolfram syndrome and WFS1 gene.","date":"2010","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20738327","citation_count":113,"is_preprint":false},{"pmid":"16648378","id":"PMC_16648378","title":"Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene.","date":"2006","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16648378","citation_count":105,"is_preprint":false},{"pmid":"9027481","id":"PMC_9027481","title":"Wolfram (DIDMOAD) syndrome and Leber hereditary optic neuropathy (LHON) are associated with distinct mitochondrial DNA haplotypes.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9027481","citation_count":85,"is_preprint":false},{"pmid":"12649740","id":"PMC_12649740","title":"The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells.","date":"2003","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12649740","citation_count":82,"is_preprint":false},{"pmid":"16151413","id":"PMC_16151413","title":"Mutation analysis of the WFS1 gene in seven Danish Wolfram syndrome families; four new mutations identified.","date":"2005","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/16151413","citation_count":76,"is_preprint":false},{"pmid":"18551525","id":"PMC_18551525","title":"Distribution of Wfs1 protein in the central nervous system of the mouse and its relation to clinical symptoms of the Wolfram syndrome.","date":"2008","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18551525","citation_count":75,"is_preprint":false},{"pmid":"11916957","id":"PMC_11916957","title":"Association studies of genetic variation in the WFS1 gene and type 2 diabetes in U.K. populations.","date":"2002","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/11916957","citation_count":73,"is_preprint":false},{"pmid":"12073007","id":"PMC_12073007","title":"Mutations in the WFS1 gene that cause low-frequency sensorineural hearing loss are small non-inactivating mutations.","date":"2002","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12073007","citation_count":67,"is_preprint":false},{"pmid":"19041897","id":"PMC_19041897","title":"Wfs1-deficient mice display impaired behavioural adaptation in stressful environment.","date":"2008","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/19041897","citation_count":66,"is_preprint":false},{"pmid":"28039263","id":"PMC_28039263","title":"Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.","date":"2016","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/28039263","citation_count":66,"is_preprint":false},{"pmid":"17568405","id":"PMC_17568405","title":"Identification of novel mutations in WFS1 and genotype-phenotype correlation in Wolfram syndrome.","date":"2007","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/17568405","citation_count":63,"is_preprint":false},{"pmid":"11161832","id":"PMC_11161832","title":"Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees.","date":"2001","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11161832","citation_count":61,"is_preprint":false},{"pmid":"19293327","id":"PMC_19293327","title":"Wfs1 gene deletion causes growth retardation in mice and interferes with the growth hormone pathway.","date":"2009","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19293327","citation_count":57,"is_preprint":false},{"pmid":"25211237","id":"PMC_25211237","title":"Wolfram syndrome in the Japanese population; molecular analysis of WFS1 gene and characterization of clinical features.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25211237","citation_count":56,"is_preprint":false},{"pmid":"19125190","id":"PMC_19125190","title":"Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19125190","citation_count":56,"is_preprint":false},{"pmid":"21199859","id":"PMC_21199859","title":"Wolfram syndrome 1 gene (WFS1) product localizes to secretory granules and determines granule acidification in pancreatic beta-cells.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21199859","citation_count":55,"is_preprint":false},{"pmid":"17492394","id":"PMC_17492394","title":"Mutations in the WFS1 gene are a frequent cause of autosomal dominant nonsyndromic low-frequency hearing loss in Japanese.","date":"2007","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17492394","citation_count":54,"is_preprint":false},{"pmid":"18060660","id":"PMC_18060660","title":"Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program.","date":"2007","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/18060660","citation_count":54,"is_preprint":false},{"pmid":"23531866","id":"PMC_23531866","title":"Wolfram gene (WFS1) mutation causes autosomal dominant congenital nuclear cataract in humans.","date":"2013","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/23531866","citation_count":49,"is_preprint":false},{"pmid":"20069065","id":"PMC_20069065","title":"Autosomal dominant optic neuropathy and sensorineual hearing loss associated with a novel mutation of WFS1.","date":"2010","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/20069065","citation_count":49,"is_preprint":false},{"pmid":"23035048","id":"PMC_23035048","title":"Vacuolar-type H+-ATPase V1A subunit is a molecular partner of Wolfram syndrome 1 (WFS1) protein, which regulates its expression and stability.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23035048","citation_count":47,"is_preprint":false},{"pmid":"18806274","id":"PMC_18806274","title":"WFS1 mutations are frequent monogenic causes of juvenile-onset diabetes mellitus in Lebanon.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18806274","citation_count":47,"is_preprint":false},{"pmid":"15605410","id":"PMC_15605410","title":"Wolfram syndrome in French population: characterization of novel mutations and polymorphisms in the WFS1 gene.","date":"2005","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15605410","citation_count":46,"is_preprint":false},{"pmid":"27395765","id":"PMC_27395765","title":"WFS1 in Optic Neuropathies: Mutation Findings in Nonsyndromic Optic Atrophy and Assessment of Clinical Severity.","date":"2016","source":"Ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/27395765","citation_count":45,"is_preprint":false},{"pmid":"12707947","id":"PMC_12707947","title":"Wolfram syndrome and suicide: Evidence for a role of WFS1 in suicidal and impulsive behavior.","date":"2003","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12707947","citation_count":45,"is_preprint":false},{"pmid":"12650300","id":"PMC_12650300","title":"Wolfram (DIDMOAD) syndrome: a multidisciplinary clinical study in nine Turkish patients and review of the literature.","date":"2003","source":"Acta paediatrica (Oslo, Norway : 1992)","url":"https://pubmed.ncbi.nlm.nih.gov/12650300","citation_count":44,"is_preprint":false},{"pmid":"24890733","id":"PMC_24890733","title":"Mutation update and uncommon phenotypes in a French cohort of 96 patients with WFS1-related disorders.","date":"2014","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24890733","citation_count":42,"is_preprint":false},{"pmid":"30014265","id":"PMC_30014265","title":"Identification of a missense variant in the WFS1 gene that causes a mild form of Wolfram syndrome and is associated with risk for type 2 diabetes in Ashkenazi Jewish individuals.","date":"2018","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/30014265","citation_count":41,"is_preprint":false},{"pmid":"12707373","id":"PMC_12707373","title":"Molecular characterization of WFS1 in patients with Wolfram syndrome.","date":"2003","source":"The Journal of molecular diagnostics : JMD","url":"https://pubmed.ncbi.nlm.nih.gov/12707373","citation_count":39,"is_preprint":false},{"pmid":"18544103","id":"PMC_18544103","title":"Autosomal dominant transmission of diabetes and congenital hearing impairment secondary to a missense mutation in the WFS1 gene.","date":"2008","source":"Diabetic medicine : a journal of the British Diabetic Association","url":"https://pubmed.ncbi.nlm.nih.gov/18544103","citation_count":37,"is_preprint":false},{"pmid":"29529044","id":"PMC_29529044","title":"WFS1 mutation screening in a large series of Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29529044","citation_count":36,"is_preprint":false},{"pmid":"34848728","id":"PMC_34848728","title":"WFS1 functions in ER export of vesicular cargo proteins in pancreatic β-cells.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34848728","citation_count":35,"is_preprint":false},{"pmid":"29357349","id":"PMC_29357349","title":"Knockdown of wfs1, a fly homolog of Wolfram syndrome 1, in the nervous system increases susceptibility to age- and stress-induced neuronal dysfunction and degeneration in Drosophila.","date":"2018","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29357349","citation_count":35,"is_preprint":false},{"pmid":"19042979","id":"PMC_19042979","title":"Identification of novel mutations of the WFS1 gene in Brazilian patients with Wolfram syndrome.","date":"2008","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19042979","citation_count":35,"is_preprint":false},{"pmid":"10424813","id":"PMC_10424813","title":"A gene for autosomal dominant hearing impairment (DFNA14) maps to a region on chromosome 4p16.3 that does not overlap the DFNA6 locus.","date":"1999","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10424813","citation_count":33,"is_preprint":false},{"pmid":"24823368","id":"PMC_24823368","title":"Impairment of visual function and retinal ER stress activation in Wfs1-deficient mice.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24823368","citation_count":33,"is_preprint":false},{"pmid":"10760554","id":"PMC_10760554","title":"WFS1 gene mutation search in depressive patients: detection of five missense polymorphisms but no association with depression or bipolar affective disorder.","date":"2000","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/10760554","citation_count":33,"is_preprint":false},{"pmid":"15522226","id":"PMC_15522226","title":"Endoplasmic reticulum stress and N-glycosylation modulate expression of WFS1 protein.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15522226","citation_count":32,"is_preprint":false},{"pmid":"19523951","id":"PMC_19523951","title":"Expression of the diabetes risk gene wolframin (WFS1) in the human retina.","date":"2009","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/19523951","citation_count":32,"is_preprint":false},{"pmid":"12707188","id":"PMC_12707188","title":"Progression of low-frequency sensorineural hearing loss (DFNA6/14-WFS1).","date":"2003","source":"Archives of otolaryngology--head & neck surgery","url":"https://pubmed.ncbi.nlm.nih.gov/12707188","citation_count":31,"is_preprint":false},{"pmid":"32949681","id":"PMC_32949681","title":"Function of WFS1 and WFS2 in the Central Nervous System: Implications for Wolfram Syndrome and Alzheimer's disease.","date":"2020","source":"Neuroscience and biobehavioral reviews","url":"https://pubmed.ncbi.nlm.nih.gov/32949681","citation_count":30,"is_preprint":false},{"pmid":"21726277","id":"PMC_21726277","title":"Presentation and clinical course of Wolfram (DIDMOAD) syndrome from North India.","date":"2011","source":"Diabetic medicine : a journal of the British Diabetic Association","url":"https://pubmed.ncbi.nlm.nih.gov/21726277","citation_count":30,"is_preprint":false},{"pmid":"37759745","id":"PMC_37759745","title":"Genomics of Wolfram Syndrome 1 (WFS1).","date":"2023","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/37759745","citation_count":29,"is_preprint":false},{"pmid":"7045512","id":"PMC_7045512","title":"The syndrome of diabetes insipidus, diabetes mellitus, optic atrophy, deafness, and other abnormalities (DIDMOAD-syndrome). Two affected sibs and a short review of the literature (98 cases).","date":"1982","source":"Klinische Wochenschrift","url":"https://pubmed.ncbi.nlm.nih.gov/7045512","citation_count":28,"is_preprint":false},{"pmid":"25250959","id":"PMC_25250959","title":"Identification of a novel missense mutation in the WFS1 gene as a cause of autosomal dominant nonsyndromic sensorineural hearing loss in all-frequencies.","date":"2014","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25250959","citation_count":28,"is_preprint":false},{"pmid":"12107816","id":"PMC_12107816","title":"WFS1 mutations in Spanish patients with diabetes mellitus and deafness.","date":"2002","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/12107816","citation_count":28,"is_preprint":false},{"pmid":"37415600","id":"PMC_37415600","title":"Genotype and clinical characteristics of patients with Wolfram syndrome and WFS1-related disorders.","date":"2023","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37415600","citation_count":27,"is_preprint":false},{"pmid":"34582248","id":"PMC_34582248","title":"Uniting the divergent Wolfram syndrome-linked proteins WFS1 and CISD2 as modulators of Ca2+ signaling.","date":"2021","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/34582248","citation_count":27,"is_preprint":false},{"pmid":"19664290","id":"PMC_19664290","title":"Male mice with deleted Wolframin (Wfs1) gene have reduced fertility.","date":"2009","source":"Reproductive biology and endocrinology : RB&E","url":"https://pubmed.ncbi.nlm.nih.gov/19664290","citation_count":27,"is_preprint":false},{"pmid":"21461749","id":"PMC_21461749","title":"Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin.","date":"2011","source":"Journal of physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21461749","citation_count":27,"is_preprint":false},{"pmid":"10437687","id":"PMC_10437687","title":"Autosomal dominant non-syndromal low-frequency sensorineural hearing impairment linked to chromosome 4p16 (DFNA14): statistical analysis of hearing threshold in relation to age and evaluation of vestibulo-ocular functions.","date":"1999","source":"Audiology : official organ of the International Society of Audiology","url":"https://pubmed.ncbi.nlm.nih.gov/10437687","citation_count":26,"is_preprint":false},{"pmid":"35399956","id":"PMC_35399956","title":"Loss of Function of WFS1 Causes ER Stress-Mediated Inflammation in Pancreatic Beta-Cells.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/35399956","citation_count":26,"is_preprint":false},{"pmid":"25447309","id":"PMC_25447309","title":"ATF6β regulates the Wfs1 gene and has a cell survival role in the ER stress response in pancreatic β-cells.","date":"2014","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/25447309","citation_count":26,"is_preprint":false},{"pmid":"12181639","id":"PMC_12181639","title":"Confirmation of genetic homogeneity of nonsyndromic low-frequency sensorineural hearing loss by linkage analysis and a DFNA6/14 mutation in a Japanese family.","date":"2002","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12181639","citation_count":25,"is_preprint":false},{"pmid":"16639390","id":"PMC_16639390","title":"Wolfram/DIDMOAD syndrome, a heterogenic and molecularly complex neurodegenerative disease.","date":"2006","source":"Pediatric endocrinology reviews : PER","url":"https://pubmed.ncbi.nlm.nih.gov/16639390","citation_count":24,"is_preprint":false},{"pmid":"33693650","id":"PMC_33693650","title":"Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation.","date":"2021","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33693650","citation_count":24,"is_preprint":false},{"pmid":"23321269","id":"PMC_23321269","title":"Silencing of the WFS1 gene in HEK cells induces pathways related to neurodegeneration and mitochondrial damage.","date":"2013","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/23321269","citation_count":23,"is_preprint":false},{"pmid":"36764396","id":"PMC_36764396","title":"Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum.","date":"2023","source":"Survey of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/36764396","citation_count":22,"is_preprint":false},{"pmid":"12565131","id":"PMC_12565131","title":"No association of mutations and mRNA expression of WFS1/wolframin with bipolar disorder in humans.","date":"2003","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/12565131","citation_count":22,"is_preprint":false},{"pmid":"27341211","id":"PMC_27341211","title":"Expression pattern of wolframin, the WFS1 (Wolfram syndrome-1 gene) product, in common marmoset (Callithrix jacchus) cochlea.","date":"2016","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/27341211","citation_count":21,"is_preprint":false},{"pmid":"21356526","id":"PMC_21356526","title":"Identification of two novel missense WFS1 mutations, H696Y and R703H, in patients with non-syndromic low-frequency sensorineural hearing loss.","date":"2011","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/21356526","citation_count":21,"is_preprint":false},{"pmid":"37163979","id":"PMC_37163979","title":"Depletion of WFS1 compromises mitochondrial function in hiPSC-derived neuronal models of Wolfram syndrome.","date":"2023","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37163979","citation_count":20,"is_preprint":false},{"pmid":"19428703","id":"PMC_19428703","title":"Wolfram syndrome 1 (Wfs1) mRNA expression in the normal mouse brain during postnatal development.","date":"2009","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/19428703","citation_count":20,"is_preprint":false},{"pmid":"17968352","id":"PMC_17968352","title":"WFS1 gene as a putative biomarker for development of post-traumatic syndrome in an animal model.","date":"2007","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17968352","citation_count":20,"is_preprint":false},{"pmid":"33879153","id":"PMC_33879153","title":"A novel mutation of WFS1 gene leading to increase ER stress and cell apoptosis is associated an autosomal dominant form of Wolfram syndrome type 1.","date":"2021","source":"BMC endocrine disorders","url":"https://pubmed.ncbi.nlm.nih.gov/33879153","citation_count":20,"is_preprint":false},{"pmid":"27053292","id":"PMC_27053292","title":"RNA-sequencing of WFS1-deficient pancreatic islets.","date":"2016","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/27053292","citation_count":19,"is_preprint":false},{"pmid":"24694561","id":"PMC_24694561","title":"Initiation and developmental dynamics of Wfs1 expression in the context of neural differentiation and ER stress in mouse forebrain.","date":"2014","source":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24694561","citation_count":19,"is_preprint":false},{"pmid":"23396150","id":"PMC_23396150","title":"Evidence for impaired function of dopaminergic system in Wfs1-deficient mice.","date":"2013","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/23396150","citation_count":19,"is_preprint":false},{"pmid":"38651637","id":"PMC_38651637","title":"The Wolfram-like variant WFS1E864K destabilizes MAM and compromises autophagy and mitophagy in human and mice.","date":"2024","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/38651637","citation_count":18,"is_preprint":false},{"pmid":"26435059","id":"PMC_26435059","title":"Phenotype Prediction of Pathogenic Nonsynonymous Single Nucleotide Polymorphisms in WFS1.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26435059","citation_count":18,"is_preprint":false},{"pmid":"18688868","id":"PMC_18688868","title":"Autoimmune disease in a DFNA6/14/38 family carrying a novel missense mutation in WFS1.","date":"2008","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/18688868","citation_count":17,"is_preprint":false},{"pmid":"35659607","id":"PMC_35659607","title":"Propionigenium and Vibrio species identified as possible component causes of shrimp white feces syndrome (WFS) associated with the microsporidian Enterocytozoon hepatopenaei.","date":"2022","source":"Journal of invertebrate pathology","url":"https://pubmed.ncbi.nlm.nih.gov/35659607","citation_count":17,"is_preprint":false},{"pmid":"17517145","id":"PMC_17517145","title":"A novel mutation in the WFS1 gene identified in a Taiwanese family with low-frequency hearing impairment.","date":"2007","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17517145","citation_count":17,"is_preprint":false},{"pmid":"12650912","id":"PMC_12650912","title":"Identification of a novel mutation in WFS1 in a family affected by low-frequency hearing impairment.","date":"2003","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/12650912","citation_count":16,"is_preprint":false},{"pmid":"37185285","id":"PMC_37185285","title":"Mutation analysis of pathogenic non-synonymous single nucleotide polymorphisms (nsSNPs) in WFS1 gene through computational approaches.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37185285","citation_count":16,"is_preprint":false},{"pmid":"33552119","id":"PMC_33552119","title":"Wfs1 and Related Molecules as Key Candidate Genes in the Hippocampus of Depression.","date":"2021","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33552119","citation_count":16,"is_preprint":false},{"pmid":"15151504","id":"PMC_15151504","title":"Study of the WFS1 gene and mitochondrial DNA in Spanish Wolfram syndrome families.","date":"2004","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15151504","citation_count":16,"is_preprint":false},{"pmid":"9309689","id":"PMC_9309689","title":"Analysis of the mitochondrial DNA from patients with Wolfram (DIDMOAD) syndrome.","date":"1997","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9309689","citation_count":16,"is_preprint":false},{"pmid":"23257691","id":"PMC_23257691","title":"Association of rs734312 and rs10010131 polymorphisms in WFS1 gene with type 2 diabetes mellitus: a meta-analysis.","date":"2012","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/23257691","citation_count":15,"is_preprint":false},{"pmid":"15234338","id":"PMC_15234338","title":"Genetic variations in the WFS1 gene in Japanese with type 2 diabetes and bipolar disorder.","date":"2004","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15234338","citation_count":15,"is_preprint":false},{"pmid":"38642554","id":"PMC_38642554","title":"Astrocyte-mediated regulation of BLAWFS1 neurons alleviates risk-assessment deficits in DISC1-N mice.","date":"2024","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/38642554","citation_count":14,"is_preprint":false},{"pmid":"32219690","id":"PMC_32219690","title":"Effect of 4-phenylbutyrate and valproate on dominant mutations of WFS1 gene in Wolfram syndrome.","date":"2020","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/32219690","citation_count":14,"is_preprint":false},{"pmid":"25385034","id":"PMC_25385034","title":"Wfs1-deficient animals have brain-region-specific changes of Na+, K+-ATPase activity and mRNA expression of α1 and β1 subunits.","date":"2014","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/25385034","citation_count":14,"is_preprint":false},{"pmid":"37277527","id":"PMC_37277527","title":"The genetic and clinical characteristics of WFS1 related diabetes in Chinese early onset type 2 diabetes.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37277527","citation_count":13,"is_preprint":false},{"pmid":"37386014","id":"PMC_37386014","title":"Wfs1E864K knock-in mice illuminate the fundamental role of Wfs1 in endocochlear potential production.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37386014","citation_count":13,"is_preprint":false},{"pmid":"12438850","id":"PMC_12438850","title":"Autosomal dominant low-frequency hearing impairment (DFNA6/14): a clinical and genetic family study.","date":"2002","source":"Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology","url":"https://pubmed.ncbi.nlm.nih.gov/12438850","citation_count":13,"is_preprint":false},{"pmid":"26426397","id":"PMC_26426397","title":"Micro-RNA Binding Site Polymorphisms in the WFS1 Gene Are Risk Factors of Diabetes Mellitus.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26426397","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49596,"output_tokens":5149,"usd":0.113012,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13542,"output_tokens":4838,"usd":0.09433,"stage2_stop_reason":"end_turn"},"total_usd":0.207342,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"WFS1 encodes a predicted transmembrane protein (wolframin) expressed in various tissues including brain and pancreas; loss-of-function mutations in both alleles cause Wolfram syndrome, establishing it as the disease gene on chromosome 4p16.\",\n      \"method\": \"Positional cloning, candidate gene screening, mutation analysis in Wolfram syndrome patients\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — positional cloning with direct mutation identification in patients, replicated across multiple subsequent studies\",\n      \"pmids\": [\"9817917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"WFS1 protein (wolframin) is an integral, endoglycosidase H-sensitive membrane glycoprotein that localizes primarily to the endoplasmic reticulum (ER); no co-localization with mitochondria was detected, arguing against a mitochondrial-mediated disorder mechanism.\",\n      \"method\": \"Immunofluorescence, subcellular fractionation, endoglycosidase H sensitivity assay, co-localization with ER marker in cultured cells\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal biochemical and imaging methods in one study; ER localization replicated by multiple subsequent labs\",\n      \"pmids\": [\"11181571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Wolframin contains nine transmembrane segments with N-cytoplasmic/C-luminal (N(cyt)/C(lum)) topology, assembles into higher molecular weight complexes (~400 kDa) in the membrane, and undergoes N-glycosylation (essential for biogenesis and stability) but lacks proteolytic processing. Missense mutation R629W causes instability and strongly reduced half-life of wolframin.\",\n      \"method\": \"Polyclonal antibody generation against both termini, topology mapping, pulse-chase experiments, COS-7 cell expression of mutant wolframin\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biochemical reconstitution with mutagenesis and pulse-chase in single rigorous study with multiple orthogonal methods\",\n      \"pmids\": [\"12913071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ER stress upregulates WFS1 mRNA and protein in pancreatic islets; N-glycosylation at Asn-663 and Asn-748 is required for WFS1 protein stability — glycosylation-defective mutants show increased protein turnover.\",\n      \"method\": \"ER stress induction with thapsigargin/dithiothreitol/tunicamycin, site-directed mutagenesis, pulse-chase protein stability assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — site-directed mutagenesis combined with pulse-chase stability assays in one study\",\n      \"pmids\": [\"15522226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Wfs1-null mice develop progressive beta-cell loss and impaired insulin secretion in response to glucose, accompanied by reduced cellular calcium responses to secretagogues and increased apoptosis of beta-cells under ER stress conditions; alpha-cells which barely express WFS1 are preserved.\",\n      \"method\": \"Wfs1 gene disruption in mice, glucose tolerance tests, islet isolation and insulin secretion assays, calcium imaging, immunohistochemistry, DNA fragmentation apoptosis assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO mouse model with multiple orthogonal functional readouts\",\n      \"pmids\": [\"15056606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"WFS1 is a novel component of the unfolded protein response (UPR); WFS1 mRNA and protein are induced by ER stress through IRE1 and PERK pathways; WFS1 is upregulated during insulin secretion; inactivation of WFS1 in beta-cells causes ER stress and beta-cell dysfunction.\",\n      \"method\": \"ER stress induction, siRNA knockdown of WFS1 in beta-cells, UPR pathway reporter assays, IRE1/PERK pathway analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods; replicated by multiple subsequent studies\",\n      \"pmids\": [\"16195229\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"WFS1-deficiency specifically activates the ER stress response in pancreatic beta-cells (elevated PERK phosphorylation, chaperone expression, active XBP1) but not in heart, skeletal muscle, or brown adipose tissue; this is reversed by re-expression of WFS1 or GRP78 overexpression. ER stress-induced increase in p21(CIP1) contributes to beta-cell loss through impaired cell cycle progression and increased caspase-3-mediated apoptosis.\",\n      \"method\": \"wfs1-deficient MIN6 clonal beta-cell lines, ER stress markers (PERK phosphorylation, XBP1, chaperone expression), BrdU incorporation, caspase-3 cleavage, WFS1 rescue experiments, GRP78 overexpression rescue\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rescue experiments with multiple orthogonal readouts in both primary islets and clonal cell lines\",\n      \"pmids\": [\"16571599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"WFS1 protein positively modulates ER Ca2+ levels by increasing the rate of Ca2+ uptake into the ER; store-operated Ca2+ entry parallels WFS1 expression levels.\",\n      \"method\": \"WFS1 knockdown and overexpression in HEK293 cells, ER-targeted Ca2+-sensitive aequorin photoprotein, Fura-2 Ca2+ imaging\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct Ca2+ measurement with ER-targeted aequorin combined with both gain- and loss-of-function in one study\",\n      \"pmids\": [\"16989814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Valproate (a mood stabilizer) induces WFS1 mRNA expression, activates the WFS1 promoter, and dose-dependently enhances dissociation of WFS1 from its binding partner GRP94 (an ER stress-response protein), providing a molecular mechanism for valproate's action.\",\n      \"method\": \"WFS1 promoter luciferase assay, RT-PCR, co-immunoprecipitation of WFS1-GRP94 complex in cells treated with valproate\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP combined with reporter assay and mRNA analysis, single lab, two orthogonal methods\",\n      \"pmids\": [\"19125190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"WFS1 localizes not only to the ER but also to secretory granules in pancreatic beta-cells; WFS1-deficiency causes a 32% reduction in granular acidification, impairs proinsulin processing, and reduces the density of secretory granules docked at the plasma membrane.\",\n      \"method\": \"Immunofluorescence, electron microscopy, acidotrophic agent (DAMP) fluorescence measurement of intragranular pH, morphometric electron microscopy analysis of docked granules, proinsulin/insulin measurement\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (immunofluorescence, EM, functional acidification assay) in single rigorous study\",\n      \"pmids\": [\"21199859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"WFS1 physically interacts with the V1A subunit of the vacuolar H+-ATPase (proton pump) via its N-terminal domain; WFS1 is required for V1A subunit stability (V1A is degraded more rapidly in WFS1-depleted cells), suggesting WFS1 functions in proton pump assembly in the ER and granular acidification.\",\n      \"method\": \"Co-immunoprecipitation in HEK293 cells and endogenous Co-IP in neuroblastoma cells, V1A domain mapping (N-terminal vs C-terminal of WFS1), protein stability assays, proteasomal inhibition, WFS1 stable/transient depletion in human neuroblastoma and NT2 cells\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with endogenous proteins, domain mapping, and protein stability assays in multiple cell lines\",\n      \"pmids\": [\"23035048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ATF6β (but not ATF6α) directly binds the WFS1 promoter and induces WFS1 gene and protein expression; ATF6β knockdown increases susceptibility to ER stress-induced apoptosis in beta-cells, partly through its failure to upregulate WFS1.\",\n      \"method\": \"Microarray after ATF6β/ATF6α overexpression, promoter binding assay (ChIP/binding assay), ATF6β knockdown in INS-1 cells, apoptosis assay\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter binding combined with KD rescue and apoptosis readout, single lab\",\n      \"pmids\": [\"25447309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"WFS1 acts as a vesicular cargo receptor for ER-to-Golgi transport: it directly binds vesicular cargo proteins including proinsulin via its ER-luminal C-terminal segment, and its cytosolic N-terminal segment encodes an ER export signal recognized by COPII subunit SEC24. WFS1 deficiency causes abnormal ER accumulation of proinsulin, impairing proinsulin processing and insulin secretion. Pathogenic mutations in the C-terminal luminal region disrupt cargo binding.\",\n      \"method\": \"Co-IP/pulldown of WFS1 with proinsulin and other cargo proteins, COPII vesicle reconstitution, SEC24 binding assays, domain mutagenesis, WFS1 KO cells, proinsulin trafficking and processing assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution of COPII vesicle formation, direct binding assays with mutagenesis, and loss-of-function cellular readout in one rigorous study\",\n      \"pmids\": [\"34848728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"WFS1 deficiency in peripheral blood mononuclear cells (PBMCs) and silencing via siRNA induces production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) without any exogenous stimulus, and promotes a Th17/Treg imbalance, indicating WFS1 regulates anti-inflammatory responses.\",\n      \"method\": \"WFS1 siRNA silencing in control PBMCs, cytokine measurement by ELISA, T-cell subset analysis (Th17/Treg) by flow cytometry in WS patient PBMCs\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with cytokine and flow cytometry readouts; single lab\",\n      \"pmids\": [\"33693650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Loss of WFS1 function enhances pro-inflammatory cytokine and chemokine expression in pancreatic beta-cells; PERK and IRE1α pathways mediate high glucose-induced inflammation; WFS1 whole-body KO mice show M1-macrophage infiltration and hypervascularization of pancreatic islets.\",\n      \"method\": \"WFS1-deficient beta-cell model, qPCR for pro-inflammatory gene expression, Wfs1 KO mouse pancreatic islet histology, macrophage immunostaining\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro WFS1 KO cell model combined with in vivo mouse histology, single lab\",\n      \"pmids\": [\"35399956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"WFS1 (Wfs1E864K knock-in) is required for endocochlear potential (EP) production in the stria vascularis; the WFS1E864K mutation prevents localization of the Na+/K+-ATPase β1 subunit to the cell surface, collapsing the EP and causing profound deafness.\",\n      \"method\": \"Wfs1E864K knock-in mouse model, EP measurement, stria vascularis histology, Na+/K+-ATPase β1 subunit localization by immunofluorescence, auditory brainstem response (ABR)\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knock-in model with direct EP measurement and mechanistic protein localization assay; single lab but multiple orthogonal readouts\",\n      \"pmids\": [\"37386014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"WFS1 interacts with VDAC1 at mitochondria-associated ER membranes (MAMs); loss of WFS1-VDAC1 interaction in Wolfram syndrome patient-derived hiPSC neurons correlates with mitochondrial dysfunction, reduced MAMs, and impaired bioenergetics; restoring WFS1 levels reinstates VDAC1 interaction, increases MAMs, and improves mitochondrial function.\",\n      \"method\": \"Co-IP of WFS1 with VDAC1 in hiPSC-derived neurons, mitochondrial function assays (OCR), MAM quantification by electron microscopy, WFS1 overexpression rescue, pharmacological agents modulating mitochondrial function\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP in human iPSC-derived neurons with rescue experiments and multiple functional readouts in a single rigorous study\",\n      \"pmids\": [\"37163979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"WFS1E864K (Wolfram-like syndrome mutation) decreases MAM number, reduces ER-to-mitochondria Ca2+ transfer, impairs mitochondrial bioenergetics and Ca2+ uptake, and deregulates autophagy/mitophagy flux in human fibroblasts and murine neuronal cultures; these are similar pathophysiological mechanisms to those in Wolfram syndrome.\",\n      \"method\": \"Human WLS fibroblasts and murine neuronal cultures, mitochondrial bioenergetics (OCR), Ca2+ uptake assays, MAM quantification by electron microscopy, autophagic flux assays (bafilomycin A1), mitophagy assays\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal functional assays in patient-derived cells; single lab\",\n      \"pmids\": [\"38651637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"WFS1-expressing glutamatergic neurons in the basolateral amygdala (BLA) have their excitability modulated by adjacent astrocytes via D-serine acting on NMDA receptors; optogenetic activation of BLA astrocytes restores BLAWFS1 neuron firing and risk-assessment behavior in a DISC1-N mouse model.\",\n      \"method\": \"Single-nucleus RNA sequencing to identify BLAWFS1 neurons, patch-clamp electrophysiology, optogenetic astrocyte activation, NMDA receptor pharmacology, real-time RT-PCR\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — optogenetics combined with electrophysiology and pharmacology; defines circuit role of WFS1 neurons but single lab\",\n      \"pmids\": [\"38642554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Dominant WFS1 mutants (p.His313Tyr, p.Trp314Arg, p.Asp325_Ile328del, p.Glu809Lys, p.Glu864Lys) exert a dominant-negative effect on wild-type WFS1, increasing ER stress (ERSE-luciferase) and CHOP mRNA; treatment with 4-phenylbutyrate or valproate reduces ER stress and cell apoptosis caused by these mutants.\",\n      \"method\": \"ERSE-luciferase ER stress reporter assay with dominant mutant co-expression, CHOP mRNA qPCR, cell viability assays, PBA/VPA pharmacological treatment\",\n      \"journal\": \"Journal of endocrinological investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — luciferase reporter assay with multiple mutants; dominant-negative mechanism established by co-expression approach in single lab\",\n      \"pmids\": [\"32219690\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"WFS1 (wolframin) is a multi-spanning ER transmembrane glycoprotein that (1) acts as a vesicular cargo receptor by binding proinsulin and other secretory proteins via its luminal C-terminus and presenting an ER export signal on its cytosolic N-terminus to SEC24/COPII for ER-to-Golgi trafficking; (2) is a key component of the unfolded protein response whose expression is induced by ER stress through IRE1/PERK/ATF6β pathways; (3) modulates ER Ca2+ levels by promoting Ca2+ uptake and filling of the ER store; (4) interacts with the V1A subunit of vacuolar H+-ATPase to stabilize the proton pump and support secretory granule acidification and proinsulin processing; (5) localizes to mitochondria-associated ER membranes (MAMs) where it binds VDAC1 to support mitochondrial Ca2+ transfer and bioenergetics; (6) interacts with GRP94 in the ER and with Na+/K+-ATPase β1 subunit in the stria vascularis cochlea to maintain the endocochlear potential; and (7) suppresses ER stress-mediated inflammation, apoptosis, and beta-cell loss, with its deficiency causing chronic ER stress, impaired insulin secretion, and progressive neurodegeneration underlying Wolfram syndrome.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"WFS1 (wolframin) is a multi-spanning, N-glycosylated endoplasmic reticulum transmembrane protein that maintains ER homeostasis and secretory function, and whose biallelic loss-of-function mutations cause Wolfram syndrome [#0, #1, #2]. It is an integral ER glycoprotein with nine transmembrane segments and N-cytoplasmic/C-luminal topology that assembles into ~400 kDa complexes, and its N-glycosylation is essential for protein stability [#1, #2, #3]. WFS1 functions as a vesicular cargo receptor for ER-to-Golgi transport, binding proinsulin and other secretory cargo through its luminal C-terminal segment while presenting a cytosolic N-terminal ER export signal recognized by the COPII subunit SEC24; its deficiency causes ER accumulation of proinsulin and impaired insulin secretion [#12]. Beyond trafficking, WFS1 is an integral component of the unfolded protein response, with its expression induced by ER stress through the IRE1, PERK, and ATF6\\u03b2 arms, and it restrains ER stress-driven apoptosis in pancreatic beta-cells [#5, #6, #11]. It supports secretory granule acidification and proinsulin processing by binding and stabilizing the V1A subunit of the vacuolar H+-ATPase [#9, #10], and it positively modulates ER Ca2+ uptake [#7]. At mitochondria-associated ER membranes WFS1 binds VDAC1 to sustain ER-to-mitochondria Ca2+ transfer and bioenergetics [#16, #17], and in the cochlear stria vascularis it is required for surface localization of the Na+/K+-ATPase \\u03b21 subunit and the endocochlear potential [#15]. WFS1 deficiency triggers chronic ER stress, progressive beta-cell loss, and pro-inflammatory responses, mechanistically linking the protein to the diabetes, deafness, and neurodegeneration of Wolfram syndrome [#4, #13, #14].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established that WFS1 is the causative gene for Wolfram syndrome, framing all subsequent mechanistic work as defining how a transmembrane protein causes a multisystem disorder.\",\n      \"evidence\": \"Positional cloning and mutation analysis in Wolfram syndrome patients\",\n      \"pmids\": [\"9817917\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define subcellular localization or molecular function\", \"No biochemical activity assigned\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Answered where wolframin acts by showing it is an ER-resident integral membrane glycoprotein, redirecting the field away from a mitochondrial-primary mechanism.\",\n      \"evidence\": \"Immunofluorescence, subcellular fractionation, and endoglycosidase H sensitivity in cultured cells\",\n      \"pmids\": [\"11181571\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No molecular function or topology defined\", \"Did not address later-described MAM/mitochondrial coupling\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined the protein architecture, showing nine transmembrane segments, N-cyt/C-lum topology, oligomerization into ~400 kDa complexes, and that glycosylation and the R629W mutation control stability.\",\n      \"evidence\": \"Topology mapping, pulse-chase, and mutant expression in COS-7 cells\",\n      \"pmids\": [\"12913071\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Function of the luminal/cytosolic termini not assigned\", \"Composition of the higher-order complex unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Linked WFS1 to the ER stress response and beta-cell survival, showing ER stress induces WFS1 and that its loss causes progressive beta-cell apoptosis and impaired glucose-stimulated insulin secretion.\",\n      \"evidence\": \"Wfs1-null mice with glucose tolerance, insulin secretion, calcium imaging, and apoptosis assays; ER-stress-induced WFS1 with glycosylation-dependent stability in islets\",\n      \"pmids\": [\"15056606\", \"15522226\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular target by which WFS1 limits apoptosis not identified\", \"Mechanism of reduced calcium responses unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Positioned WFS1 as a UPR component induced via IRE1/PERK whose loss causes beta-cell-specific chronic ER stress, with rescue by WFS1 or GRP78 re-expression and p21-driven cell-cycle/apoptosis defects.\",\n      \"evidence\": \"siRNA knockdown and WFS1/GRP78 rescue in beta-cell lines and islets with UPR markers, BrdU, and caspase-3 readouts\",\n      \"pmids\": [\"16195229\", \"16571599\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical role of WFS1 within the UPR not defined\", \"Tissue specificity mechanism unexplained\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Assigned a calcium-handling function, showing WFS1 levels positively set the rate of ER Ca2+ uptake and store-operated entry.\",\n      \"evidence\": \"Knockdown/overexpression in HEK293 cells with ER-targeted aequorin and Fura-2 imaging\",\n      \"pmids\": [\"16989814\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of Ca2+ regulation (channel/pump partner) not identified\", \"Relationship to UPR induction unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Extended WFS1 function to secretory granules, showing it is required for granular acidification, proinsulin processing, and granule docking.\",\n      \"evidence\": \"Immunofluorescence, EM, DAMP intragranular pH measurement, and morphometry in beta-cells\",\n      \"pmids\": [\"21199859\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of acidification defect not yet defined\", \"Did not identify the proton-pump partner\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Provided a mechanism for acidification by showing WFS1 binds and stabilizes the vacuolar H+-ATPase V1A subunit via its N-terminal domain.\",\n      \"evidence\": \"Reciprocal endogenous Co-IP, domain mapping, and protein stability assays in HEK293 and neuroblastoma cells\",\n      \"pmids\": [\"23035048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry within the ~400 kDa complex unresolved\", \"Direct vs indirect stabilization not distinguished\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified ATF6\\u03b2 as a direct transcriptional inducer of WFS1, separating ATF6\\u03b2 from ATF6\\u03b1 in protecting beta-cells from ER-stress apoptosis.\",\n      \"evidence\": \"Microarray, promoter binding, and ATF6\\u03b2 knockdown with apoptosis assays in INS-1 cells\",\n      \"pmids\": [\"25447309\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; reciprocal validation limited\", \"Quantitative contribution of WFS1 to ATF6\\u03b2 protection not isolated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined WFS1's core molecular activity as a COPII cargo receptor, showing direct luminal binding of proinsulin and other cargo and an N-terminal ER export signal recognized by SEC24, with pathogenic luminal mutations disrupting cargo binding.\",\n      \"evidence\": \"Co-IP/pulldown, COPII vesicle reconstitution, SEC24 binding, domain mutagenesis, and trafficking assays in WFS1 KO cells\",\n      \"pmids\": [\"34848728\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repertoire of cargo proteins not catalogued\", \"Reconciliation with UPR and Ca2+ roles within one mechanism not established\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Implicated WFS1 in immune regulation, showing its loss drives spontaneous pro-inflammatory cytokine production and Th17/Treg imbalance in immune cells.\",\n      \"evidence\": \"siRNA silencing in PBMCs with ELISA cytokine measurement and flow cytometry of T-cell subsets\",\n      \"pmids\": [\"33693650\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking WFS1 loss to cytokine induction not defined\", \"Single lab; no in vivo confirmation in this study\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established a MAM/mitochondrial role, showing WFS1 binds VDAC1 to maintain ER-mitochondria contacts and bioenergetics, with rescue restoring function.\",\n      \"evidence\": \"Co-IP, OCR, EM MAM quantification, and WFS1 overexpression rescue in Wolfram patient hiPSC-derived neurons\",\n      \"pmids\": [\"37163979\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect WFS1-VDAC1 interaction not resolved\", \"Reconciliation with earlier non-mitochondrial localization not addressed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Explained Wolfram-associated deafness, showing WFS1 is required for Na+/K+-ATPase \\u03b21 surface localization in the stria vascularis and for the endocochlear potential.\",\n      \"evidence\": \"Wfs1E864K knock-in mice with EP measurement, ABR, and \\u03b21-subunit localization\",\n      \"pmids\": [\"37386014\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether WFS1 directly traffics \\u03b21 via its cargo-receptor activity not tested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrated that the dominant E864K (Wolfram-like) mutation reduces MAMs, ER-to-mitochondria Ca2+ transfer, bioenergetics, and autophagy/mitophagy flux, unifying dominant and recessive disease mechanisms.\",\n      \"evidence\": \"OCR, Ca2+ uptake, EM MAM quantification, and autophagy/mitophagy flux assays in patient fibroblasts and murine neurons\",\n      \"pmids\": [\"38651637\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal order between Ca2+ defect and autophagy deregulation unclear\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Characterized WFS1-expressing neurons at the circuit level, defining basolateral amygdala WFS1 glutamatergic neurons whose excitability is gated by astrocyte-derived D-serine acting on NMDA receptors.\",\n      \"evidence\": \"Single-nucleus RNA-seq, patch-clamp, optogenetic astrocyte activation, and NMDA pharmacology in a DISC1-N mouse model\",\n      \"pmids\": [\"38642554\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-autonomous function of WFS1 in these neurons not tested\", \"Relationship to Wolfram neurodegeneration not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How WFS1's distinct activities — COPII cargo receptor, UPR effector, ER Ca2+ regulator, V-ATPase stabilizer, MAM/VDAC1 tether, and Na+/K+-ATPase chaperone — derive from a single molecular mechanism, and which is primary in driving each tissue's pathology, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying biochemical model integrating cargo-receptor and ER-homeostasis functions\", \"Tissue-specific primary defect (beta-cell vs cochlea vs neuron) not isolated\", \"Structure of the native oligomeric complex unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0038024\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [10, 15]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [12, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 2, 3]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [16, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [5, 6, 11]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [9, 12]}\n    ],\n    \"complexes\": [\n      \"vacuolar H+-ATPase (V1A subunit)\",\n      \"COPII (via SEC24)\",\n      \"WFS1 ~400 kDa membrane complex\"\n    ],\n    \"partners\": [\n      \"SEC24\",\n      \"ATP6V1A\",\n      \"VDAC1\",\n      \"GRP94\",\n      \"ATP1B1\",\n      \"HSPA5\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}